The management of opioid-related sedation

Current Pain and Headache Reports

Volumn 9, Issue 4, 2005, Pages 239-242

  Shaiova, Lauren ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CAFFEINE; COCAINE; DEXAMPHETAMINE; DONEPEZIL; METHADONE; METHAMPHETAMINE; METHYLPHENIDATE; MODAFINIL; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE; NARCOTIC ANALGESIC AGENT; OPIATE DERIVATIVE; PEMOLINE; PLACEBO; PSYCHOSTIMULANT AGENT; SEROTONIN UPTAKE INHIBITOR; THEOBROMINE; THEOPHYLLINE;

ANTINOCICEPTION; BODY WEIGHT DISORDER; CANCER PAIN; CANCER PATIENT; CHRONIC PAIN; CLINICAL TRIAL; DEPRESSION; DIZZINESS; DRUG CLASSIFICATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; HEADACHE; HEART INFARCTION; HUMAN; INSOMNIA; IRRITABILITY; KINESIOTHERAPY; MOOD DISORDER; MUSCLE CRAMP; NAUSEA; PHYSICIAN; PSYCHOSIS; QUALITY OF LIFE; REST; RESTLESSNESS; REVIEW; SIDE EFFECT; SKILL; SOMNOLENCE; TACHYCARDIA; TREATMENT WITHDRAWAL; VOMITING;

EID: 24044541010     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-005-0030-7     Document Type: Review

References (26)

1. Meuser T: Symptoms during cancer pain treatment following WHO guidelines: a longitudinal follow-up study of symptom prevalence, severity, and etiology. Pain 2001, 93:247-257.
2. Andersen G, Jensen NH, Christrup L, et al.: Pain, sedation, and morphine metabolism in cancer patients during long-term treatment with sustained release morphine. Palliat Med 2002, 16:107-114.
3. Ward R: Opioid tolerance to sedation and analgesia. Pediatr Res 2000, 47:705-706.
4. Cleeland C: Measuring and understanding fatigue. Proceedings of the National Comprehensive Cancer Network. Oncology 1999, 13:91-97.
5. Pearson PG, Byars G: The Development and Validation of a Checklist Measuring Subjective Fatigue [Report No:56-115]. Texas: Randolph AFB USAF School of Aviation; 1956.
6. Bruera E, Strasser F, Shen L, et al.: The effect of donepezil on sedation and other symptoms in patients receiving opioids for cancer pain: a pilot study. J Pain Symptom Manage 2003, 26:1049-1054.
7. Richardson A: Fatigue in cancer patients: a review of the literature. Eur J Can Care 1995, 4:20-32.
8. Glaus A, Crow R, Hammond S: A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Support Care Cancer 1996, 4:82-96.
9. Doyle D, Hanks G, Cherny N, Calman K: Oxford Textbook of Palliative Medicine, edn 3. Oxford: Oxford University Press; 2003.
10. Lawlor PG, Bruera E: Side effects of opioids in chronic pain treatment. Curr Opin Anaesthesiol 1998, 11:539-545.
11. Grond S, Zech D, Diefenbach C, Bischoff A: Prevalence and pattern of symptoms in patients with cancer pain-a prospective evaluation of 1635 cancer patients referred to a pain clinic. J Pain Symptom Manage 1994, 9:372-382.
12. Weber M, Huber C: Documentation of severe pain opioid doses and opioid-related side effects in outpatients with cancer: a retrospective study. J Pain Symptom Manage 1999, 17:49-54.
13. Benitez-Rosario MA, Feria M, Salinas-Martin A, et al.: Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain. Cancer 2004, 101:2866-2873.
14. Shaiova L: The role of methadone in the treatment of moderate to severe cancer pain, cancer therapy. Support Cancer Ther 2005, 2:176-180.
15. Tobias JD: A review of intraspinal and epidural analgesia in children after spinal surgery. Anesth Analg 2004, 98:956-965.
16. Black CD, O'Connor PJ, McCully KK: Increased daily physical activity and fatigue symptoms in chronic fatigue syndrome. Dyn Med 2005, 4:3.
17. Breitbart W, Rosenfeld B: A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease: opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev 2004, 3:CD004847.
18. Slatkin NE, Rhiner M, Bolton TM: Donepezil used in the treatment of opioid sedation: report of six cases. J Pain Symptom Manage 2003, 21:425-438.
19. Webster L, Andrews M, Stoddard G: Modafinil treatment of opioid-induced sedation pain medicine. Pain Med 2003, 4:135-140.
20. Jabinski DR: The abuse potential of modafinil using methylphenidate as a reference. Poster presented at the 59th Annual College on Problems of Drug Dependence. Nashville: June 14-15, 1997.
21. Yee JD, Berde CB: Dextroamphetamine or methylphenidate as adjuvants to opioids analgesia for adolescents with cancer. J Pain Symptom Manage 1994, 9:122-125.
22. Yee JD, Berde CB: Dextroamphetamine or methylphenidate as adjuvants in opioid analgesia [Abstract]. J Pain Symptom Manage 1991, 6:162.
23. Forrest WH, Brown BW, Brown CR, et al.: Dextroamphetamine with morphine for the treatment of postoperative pain. N Engl J Med 1977, 290:712-715.
24. Bruera E, Driver L, Barnes EA, et al.: Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol 2003, 21:4439-4443.
25. Wiggs JW: Amantidine, the old anti-Parkinson medication, being useful in the fatigue syndrome that often accompanies multiple sclerosis S D. J Med 1991, 44:279.
26. Lorist MM, Tops M: Caffeine, fatigue, and cognition. Brain Cogn 2003, 53:82-94.